Publications by authors named "G BIJAOUI"
Study Question: Are anti-Müllerian hormone (AMH) levels lower in women with endometriosis, notably those with endometriomas (OMAs) and deep infiltrating lesions, compared with controls without endometriosis?
Summary Answer: Endometriosis and OMAs per se do not result in lower AMH levels. AMH levels are decreased in women with previous OMA surgery independently of the presence of current OMAs.
What Is Known Already: The impact of endometriosis and OMAs per se on the ovarian reserve is controversial.
Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis.
Hum Reprod
August 2011
Article Synopsis
- The study investigates the relationship between oral contraception (OC) use and different types of endometriosis, analyzing data from over 1,000 women, including both controls and those with diagnosed endometriosis.
- Results indicate that women who have previously used OC, particularly for severe primary dysmenorrhea, show a higher incidence of endometriosis, especially deep infiltrating endometriosis (DIE).
- However, current OC users do not have an increased prevalence of endometriosis, suggesting that while past OC use may be linked to later diagnosis, it does not directly increase the risk of developing endometriosis.
Smoking habits did not influence either the risk of any form of endometriosis (superficial peritoneal endometriosis, ovarian endometriomas, and deep infiltrating endometriosis) and did not correlate with the revised American Fertility Society stages or scores.
View Article and Find Full Text PDFBackground: Matrix metalloproteinases (MMPs) may contribute to endometriosis. We tested whether eight functional polymorphisms of these genes could modify the risk of endometriosis.
Methods: In this case-control study, 227 endometriosis and 241 controls were genotyped for MMP1 -1607 1G/2G, MMP2 -1575 G/A (MMP2.